Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03755492 · ClinicalTrials.gov registry record
Initiative to Minimize Disparities in Postoperative Prostate Cancer Care
A clinical trial, sponsored by Albert Einstein Healthcare Network.
- Terminated
- Registry status
- 24
- Enrollment target
NCT03755492: Clinical Trial study, sponsored by Albert Einstein Healthcare Network.
NCT03755492 is a clinical trial that was terminated before completion, run by Albert Einstein Healthcare Network. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03755492 was terminated before completion, sponsored by Albert Einstein Healthcare Network.
- TERMINATED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Einstein Healthcare Network in North Philadelphia serves a predominantly underserved medical community. The investigators routinely see patients who cannot afford absorbent pads after prostate surgery, which helps with quality of life secondary to urinary incontinence. The investigators will provide absorbent pads to participants who would be unable to afford them. The investigators hypothesize that providing absorbent pads for 6 months will result in improved quality of life in regards to management of urinary incontinence after radical prostatectomy.
Primary Outcome
Questionnaire to assess severity of urinary incontinence and how it influences a patient's quality of life. The questionnaire asks a total of 10 questions scaled 0 to 4. The 10 questions that make up the questionnaire cover bothersome lower urinary tract symptoms specific to stress urinary incontinence, urge urinary incontinence, how many pads patients are using to manage their incontinence, and how it is influencing their daily activities. Patients with higher scores have more severe and bother
Interventions
- OTHER Absorbent pad for urinary incontinence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2022-07-20 |
Why NCT03755492 stopped before completion
NCT03755492 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Absorbent pad for urinary incontinence is the first listed.
NCT03755492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03755492 about?
NCT03755492 is a clinical study titled "Initiative to Minimize Disparities in Postoperative Prostate Cancer Care". Einstein Healthcare Network in North Philadelphia serves a predominantly underserved medical community. The investigators routinely see patients who cannot afford absorbent pads after prostate surgery, which helps with quality of life secondary to urinary incontinence. The investigators will provide...
What is the current status of trial NCT03755492?
This trial is currently terminated. The enrollment target is 24 participants. The study started on 2019-04-01. Estimated completion is 2022-07-20.
What interventions are being tested in trial NCT03755492?
The interventions under investigation include: Absorbent pad for urinary incontinence (OTHER).
Who is sponsoring clinical trial NCT03755492?
This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI